See also this year's filing and all EDGAR filings for this company.
PDF Report 0001260990_2015_Oncternal_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001260990, Oncternal Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 50,151,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 29,000 |
| 3 | remainder_Assets | 471,000 |
| 4 | LiabilitiesCurrent | 32,792,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,877,373 |
| 9 | ResearchAndDevelopmentExpense | 17,524,061 |
| 10 | remainder_Expenses | 7,912,772 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 261,780 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 50,651,000 |
| 1 | Liabilities | 32,792,000 |
| 2 | Expenses | 35,314,206 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 17,859,000 |
| 5 | NetIncome | -35,052,426 |
| 6 | ComprehensiveNetIncome | -35,052,426 |
| 7 | BaseVar | 59,509,493 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.0930 |
| 9 | EconomicCapitalRatio | 1.50 |